Martin-Quesada, Ana Isabel http://orcid.org/0000-0001-8439-6679
Llabres-Valentí, Elisenda
Montesdeoca-Godoy, Cristina María
Martín-Abreu, Carla
Alemán-Sánchez, Cristina
Rodríguez-Pérez, Natalia
Herrero-Márquez, Alicia
Cruz-Jurado, Josefina
Hernández-Sosa, María
Marrero-García, Melody
DelPino-Hernández, Cristina Victoria
Hernández-Sarmiento, Samuel José
Rodríguez-Capote, Alejandra
Pérez-Méndez, Lina
Núñez-Hernández, Isaac
Article History
Received: 28 November 2023
Accepted: 27 February 2024
First Online: 21 March 2024
Declarations
:
: The study was approved by the hospital’s ethics committee.
: Exention of Informed consent accepted by the Ethical commitee.
: Josefina Cruz-Jurado: Fee: Roche, Pfyzer, Novartis, Lilly, Glaxo, Eisai, Pierre Fabre, Pharmamar, Daichii, Astra Zaneca, Glaxo, seagen, Gilead Advisory: Roche, Pfyzer, Novartis, Lilly, Glaxo, Eisai, Pierre Fabre, Pharmamar, Daichii, Astra Zaneca, Glaxo ,seagen, Gilead. The other authors declare no conflicts of interest in relation to the current article.